Ally Bridge Group »

Flamel Technologies Sa shares owned by Ally Bridge Group

Quarter-by-quarter ownership of Flamel Technologies Sa shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in Flamel Technologies Sa

Tip: Access up to 7 years of quarterly data

All positions including Flamel Technologies Sa held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Flamel Technologies Sa by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $9.2M 547k 16.89
2023-12-31 $4.9M 347k 14.12

More positions owned by Ally Bridge Group

Blueprint Medicines (BPMC)
Soleno Therapeutics (SLNO)
Cg Oncology (CGON)
Xenon Pharmaceuticals (XENE)
Verona Pharma Sponsored Ads (VRNA)
Merus N V (MRUS)
Praxis Precision Medicines I (PRAX)
Mind Medicine Mindmed Com New (MNMD)
Avadel Pharmaceuticals Sponsored Adr
Geron Corporation (GERN)
Jasper Therapeutics Com New (JSPR)
Kura Oncology (KURA)
Insmed Com Par $.01 (INSM)
Dianthus Therapeutics (DNTH)
Olema Pharmaceuticals (OLMA)

View all positions for Ally Bridge Group

Top funds holding Flamel Technologies Sa

Rtw Investments
Polar Capital Holdings
Vivo Capital
Adage Capital Partners GP
Tri Locum Partners
MPM Oncology Impact Management
Knoll Capital Management
Ally Bridge Group
Knott David M Jr
Ameriprise Financial
Schulhoff & Company
Gts Securities
Oppenheimer & Co
Townsquare Capital
Cinctive Capital Management

View all funds holding Flamel Technologies Sa